Navamedic expands market reach for Sippi
Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, has secured distribution of its new Sippi urine measurement system in the Benelux markets. Navamedic has signed an agreement with Ecomed Services bvba of Belgium, a distributor of infection control and intensive care products.
Navamedic launched the new digital urine measurement system Sippi earlier this year in the Nordic and German markets, which in total represent 25,000 beds in intensive care units (ICUs). The distribution agreement with Ecomed adds another 5,000 ICU and critical care beds to Sippi's market reach.
"Benelux is an important European region, and I am confident that we in Ecomed have found the ideal distribution partner for these markets," said Navamedic CEO Tom Rönnlund.
The Sippi product family is a potential game changer in a NOK 2 billion market. The new digital urine measurement system aims at replacing analogue and manual systems, improving patient safety and accuracy while also saving time for the hospital staff.
For further information, please contact CEO Tom Rönnlund, telephone +46 727 320 321 or CFO Bjørn Lindholt, telephone +47 9300 6601.
About Ecomed Services bvba
Ecomed Services bvba is a leading distributor in Belgium, Luxemburg and the Netherlands within ICU and infection control. Ecomed's mission is to drive and market innovations in the field of infection prevention to the benefit of patients. To that end, Ecomed 's focus is on delivering sustainable solutions for medical applications in critical areas with a recognised level of infection risk.
About Navamedic ASA
Navamedic ASA is a Norwegian medtech and pharmaceutical products company, delivering products to patients, hospitals and pharmacies in the Nordic and Benelux markets. The Group has recently established a Medtech business unit which is currently introducing the next generation digital urine meter for use in intensive care, Sippi ®. Navamedic's Pharma and Healthcare business is a distributor of products supplied by a number of pharmaceutical manufacturers. Navamedic is listed on the Oslo Stock Exchange (ticker: NAVA).